![]() |
Name |
Hexadecamethylheptasiloxane
|
Molecular Formula | C16H48O6Si7 | |
IUPAC Name* |
bis[[[dimethyl(trimethylsilyloxy)silyl]oxy-dimethylsilyl]oxy]-dimethylsilane
|
|
SMILES |
C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C
|
|
InChI |
InChI=1S/C16H48O6Si7/c1-23(2,3)17-25(7,8)19-27(11,12)21-29(15,16)22-28(13,14)20-26(9,10)18-24(4,5)6/h1-16H3
|
|
InChIKey |
NFVSFLUJRHRSJG-UHFFFAOYSA-N
|
|
Synonyms |
541-01-5; HEXADECAMETHYLHEPTASILOXANE; Hexadecamethyl heptasiloxane; Heptasiloxane, hexadecamethyl-; 1,1,1,3,3,5,5,7,7,9,9,11,11,13,13,13-Hexadecamethylheptasiloxane; bis[[[dimethyl(trimethylsilyloxy)silyl]oxy-dimethylsilyl]oxy]-dimethylsilane; EINECS 208-763-3; Hepta(dimethylsiloxane); SCHEMBL247054; DTXSID8060242; HSDB 8420; CHEBI:132295; MFCD05663924; AKOS030227995; Heptasiloxane, 1,1,1,3,3,5,5,7,7,9,9,11,11,13,13,13-hexadecamethyl-; ZINC195751358; DS-19609; CS-0186278; I10427; A870545; Hexadecamethyl heptasiloxane** CUSTOM SYNTHESIS PLEASE ASK **; 1,1,1,3,3,5,5,7,7,9,9,11,11,13,13,13-Hexadecamethylheptasiloxane #
|
|
CAS | 541-01-5 | |
PubChem CID | 10912 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 533.1 | ALogp: | 6.3 |
HBD: | 0 | HBA: | 6 |
Rotatable Bonds: | 12 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 55.4 | Aromatic Rings: | 0 |
Heavy Atoms: | 29 | QED Weighted: | 0.276 |
Caco-2 Permeability: | -6.076 | MDCK Permeability: | 0.00013466 |
Pgp-inhibitor: | 0.024 | Pgp-substrate: | 0.917 |
Human Intestinal Absorption (HIA): | 0.997 | 20% Bioavailability (F20%): | 0.05 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0 | Plasma Protein Binding (PPB): | 116.02% |
Volume Distribution (VD): | 4.616 | Fu: | 44.61% |
CYP1A2-inhibitor: | 0.348 | CYP1A2-substrate: | 0.977 |
CYP2C19-inhibitor: | 0.787 | CYP2C19-substrate: | 0.971 |
CYP2C9-inhibitor: | 0.857 | CYP2C9-substrate: | 0.952 |
CYP2D6-inhibitor: | 0.014 | CYP2D6-substrate: | 0.922 |
CYP3A4-inhibitor: | 0.4 | CYP3A4-substrate: | 0.089 |
Clearance (CL): | 2.458 | Half-life (T1/2): | 0.153 |
hERG Blockers: | 0.47 | Human Hepatotoxicity (H-HT): | 0.002 |
Drug-inuced Liver Injury (DILI): | 0.005 | AMES Toxicity: | 0.02 |
Rat Oral Acute Toxicity: | 0 | Maximum Recommended Daily Dose: | 0.397 |
Skin Sensitization: | 0.922 | Carcinogencity: | 0.017 |
Eye Corrosion: | 1 | Eye Irritation: | 0.997 |
Respiratory Toxicity: | 0.031 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001783 | ![]() |
0.644 | D06IGU | ![]() |
0.099 | ||
ENC001784 | ![]() |
0.586 | D0H2DQ | ![]() |
0.096 | ||
ENC001271 | ![]() |
0.563 | D0Z1ZM | ![]() |
0.095 | ||
ENC000530 | ![]() |
0.506 | D06ZUP | ![]() |
0.092 | ||
ENC001785 | ![]() |
0.471 | D03HJK | ![]() |
0.089 | ||
ENC003080 | ![]() |
0.307 | D02YIZ | ![]() |
0.085 | ||
ENC001404 | ![]() |
0.277 | D04JMQ | ![]() |
0.084 | ||
ENC001122 | ![]() |
0.263 | D06EEL | ![]() |
0.082 | ||
ENC003081 | ![]() |
0.260 | D0Y7TO | ![]() |
0.078 | ||
ENC001182 | ![]() |
0.259 | D0L2UN | ![]() |
0.077 |